Drug Shortage Report for TWINRIX
Report ID | 35785 |
Drug Identification Number | 02230578 |
Brand name | TWINRIX |
Common or Proper name | Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN |
Strength(s) | 720UNIT 20MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1's |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-01-10 |
Estimated end date | 2018-01-19 |
Actual end date | 2018-01-17 |
Shortage status | Resolved |
Updated date | 2018-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-01-12 | English | Compare |
v2 | 2018-01-12 | English | Compare |
v3 | 2018-01-12 | French | Compare |
v4 | 2018-01-19 | English | Compare |
v5 | 2018-01-19 | French | Compare |
Showing 1 to 5 of 5